Inlyta Oral Tablet 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

INLYTA: Oral tablet (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

AXITINIB (ax I ti nib) is a chemotherapy drug. It targets a specific protein within cancer cells and stops the cancer cells from growing. It is used to treat kidney cancers.

In-Depth Information

INLYTA 1mg Tablet

NDC: 000690145
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Renal Cell Cancer

Storage Information
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
INLYTA 1mg Tablet

Reported Side Effects for INLYTA 1mg Tablet

Heart Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding In The Brain Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Brain Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Underactive Thyroid Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Sugar Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Coughing Up Blood Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Hole In Intestines Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Blood Pressure Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Brain Deterioration Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low Albumin In Blood Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Blood In The Urine Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Melena Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Abnormality Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Mouth Ulcers Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
High Sodium Levels Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
High Red Blood Cells Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Cough Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Bleeding Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Intestinal Bleeding Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Low Calcium Levels Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Overactive Thyroid Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Blood Clot In Eye Incidence:
1.0%*
Severity: SEVERE
Onset: DELAYED
Headache Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Stomach Pain Incidence:
2.0%*
Severity: SEVERE
Onset: EARLY
Increased Blood Sugar Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot In Lung Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Low Phosphate Level Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Skin Redness Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
High Amylase Levels Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Joint Pain Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Weight Loss Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Low Lymphocytes Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Ringing In Ears Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Protein In The Urine Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Shortness Of Breath Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Hair Loss Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Anemia Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Hemorrhoids Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
4.0%*
Severity: SEVERE
Onset: DELAYED
Weakness Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Hand And Foot Syndrome Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Nose Bleed Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
High Calcium Levels Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
7.0%*
Severity: MILD
Onset: RAPID
Lightheadedness Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
11.0%*
Severity: SEVERE
Onset: EARLY
Loose Stools Incidence:
11.0%*
Severity: SEVERE
Onset: EARLY
Metallic Taste Incidence:
11.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cells Incidence:
11.0%*
Severity: MODERATE
Onset: DELAYED
High Potassium Level Incidence:
15.0%*
Severity: SEVERE
Onset: DELAYED
High Blood Pressure Incidence:
16.0%*
Severity: SEVERE
Onset: EARLY
Hoarseness Incidence:
31.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for INLYTA 1mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and INLYTA 1mg Tablet(Axitinib)
Grapefruit juice and Axitinib(Axitinib)
Do not take Axitinib and Grapefruit Juice together without approval from your prescriber. Taking these drugs together is not recommended. If these drugs must be given together, your health care provider may change your Axitinib dose. Notify your prescriber if you have any new or worsening side effects.
Major Lifestyle Interaction
Alcohol and INLYTA 1mg Tablet(Axitinib)
Alcohol and Axitinib(Axitinib)
Do not take these together without approval from your prescriber. Taking these drugs together is not recommended. Ethanol (alcohol) may decrease the amount of Axitinib in your blood and may decrease how well Axitinib works.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with INLYTA

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5